These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. [Chlorbutin, azathioprine, d-penicillamine and dekaris (levamisole) in the treatment of rheumatoid arthritis patients. III. A comparative analysis of their effect on the morphological manifestations of synovitis based on puncture biopsy data]. Shekhter AB; Krel' AA; Chichasova NV; Rashchupkina ZP Ter Arkh; 1984; 56(2):121-31. PubMed ID: 6710393 [No Abstract] [Full Text] [Related]
6. Adverse reactions to the principal drugs used in rheumatoid arthritis--a review. Franchimont P; Heynen G; Hauwaert CH J Rheumatol Suppl; 1978; 4():85-92. PubMed ID: 282449 [TBL] [Abstract][Full Text] [Related]
7. IL-16 as an anti-inflammatory cytokine in rheumatoid synovitis. Klimiuk PA; Goronzy JJ; Weyand CM J Immunol; 1999 Apr; 162(7):4293-9. PubMed ID: 10201961 [TBL] [Abstract][Full Text] [Related]
8. Recent developments in disease-modifying antirheumatic drugs. Hunneyball IM Prog Drug Res; 1980; 24():101-216. PubMed ID: 7005959 [No Abstract] [Full Text] [Related]
9. Immune function in severe, active rheumatoid arthritis. A relationship between peripheral blood mononuclear cell proliferation to soluble antigens and synovial tissue immunohistologic characteristics. Malone DG; Wahl SM; Tsokos M; Cattell H; Decker JL; Wilder RL J Clin Invest; 1984 Oct; 74(4):1173-85. PubMed ID: 6384266 [TBL] [Abstract][Full Text] [Related]
14. [The drug spectrum in rheumatoid arthritis therapy]. Fellinger K Acta Med Austriaca; 1975; 2(4):105-10. PubMed ID: 1224926 [TBL] [Abstract][Full Text] [Related]
15. Morphological and molecular pathology of the B cell response in synovitis of rheumatoid arthritis. Magalhães R; Stiehl P; Morawietz L; Berek C; Krenn V Virchows Arch; 2002 Nov; 441(5):415-27. PubMed ID: 12447670 [TBL] [Abstract][Full Text] [Related]
16. [Antigenic markers of immunocompetent cells in rheumatoid synovial membrane]. Faure G; Bene MC; Bach MA; Bach JF; Duheille J; Gaucher A Rev Rhum Mal Osteoartic; 1983 Jun; 50(7):515-20. PubMed ID: 6225180 [TBL] [Abstract][Full Text] [Related]
17. High mobility group box chromosomal protein 1: a novel proinflammatory mediator in synovitis. Kokkola R; Sundberg E; Ulfgren AK; Palmblad K; Li J; Wang H; Ulloa L; Yang H; Yan XJ; Furie R; Chiorazzi N; Tracey KJ; Andersson U; Harris HE Arthritis Rheum; 2002 Oct; 46(10):2598-603. PubMed ID: 12384917 [TBL] [Abstract][Full Text] [Related]
18. Remission-inducing therapy in rheumatoid arthritis. Lipsky PE Am J Med; 1983 Oct; 75(4B):40-9. PubMed ID: 6356907 [TBL] [Abstract][Full Text] [Related]
19. Do drugs change the course of rheumatoid arthritis? Wright V; Amos R Br Med J; 1980 Apr; 280(6219):964-6. PubMed ID: 6106520 [No Abstract] [Full Text] [Related]
20. [Comparative effectiveness of the basic drugs used in rheumatoid arthritis (long-term randomized study)]. Tsvetkova ES Ter Arkh; 1985; 57(8):40-3. PubMed ID: 3934779 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]